Salimetrics

Salimetrics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Salimetrics is a pioneer and established leader in the salivary bioscience sector, offering a complete workflow solution from sample collection to analysis. Its business model is built on three pillars: selling collection methods and assay kits for in-lab use, providing contract research services through its SalivaLab and CoreLab+, and operating a CLIA lab for diagnostic testing. The company caters primarily to academic, government, and pharmaceutical researchers studying stress, inflammation, hormones, and social behavior through non-invasive means. Its recent expansion into dried blood spot (DBS) testing positions it as a broader specialized biospecimen analysis provider.

Diagnostics

Technology Platform

Integrated ecosystem for salivary and dried blood spot (DBS) biospecimen analysis, including specialized collection devices, validated immunoassay kits (EIAs/ELISAs), and CLIA-certified laboratory testing services.

Funding History

1
UndisclosedUndisclosed

Opportunities

The growing acceptance of non-invasive sampling in both research and clinical diagnostics presents a major expansion opportunity.
Saliva-based testing is ideal for decentralized trials, pediatric studies, and remote monitoring.
The company's CLIA lab and recent DBS capabilities position it to partner on diagnostic test development and capture more of the biomarker analysis market.

Risk Factors

Revenue is sensitive to fluctuations in academic and government research funding.
The company faces potential competition from larger diagnostic firms entering the space and technological disruption from alternative sampling methods.
Successfully navigating the regulatory and commercial challenges of the clinical diagnostics market remains a significant hurdle.

Competitive Landscape

Salimetrics is a niche leader in salivary assay kits and testing services, competing with a handful of specialized firms (e.g., DRG International, IBL International) and in-house university core facilities. For diagnostic services, it competes with large clinical labs (Quest, LabCorp) and broader biomarker analysis CROs. Its deep focus on saliva and established reputation provide a strong defensive position.